欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号PT/H/2231/001
药品名称Epirrubicina Kabi
活性成分
    • Epirubicin hydrochloride 2.0 mg/ml
剂型Solution for injection
上市许可持有人RMS transfer from UK/H/1509/01/MR Fresenius Kabi Oncology Plc.
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • Malta (MT)
    • Belgium (BE)
    • Spain (ES)
    • Poland (PL)
    • Germany (DE)
      Epirubicin-Hydrochlorid 2 mg/ml Injektionslösung
    • Greece (GR)
    • Ireland (IE)
    • United Kingdom (Northern Ireland) (XI)
      PL 18727/0008 - 0026
    • Latvia (LV)
    • Lithuania (LT)
      Epirubicin Kabi 2 mg/ml injekcinis/ infuzinis tirpalas
    • Estonia (EE)
    • Bulgaria (BG)
      Epirubicin Kabi
许可日期2009/03/10
最近更新日期2024/11/26
药物ATC编码
    • L01DB03 epirubicin
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase